Shandong Weigao Group Medical Polymer Company Limited (1066) released a proxy form for its extraordinary general meeting, set for 17 December 2025 at 8:30 a.m. at the company’s office in Weihai, Shandong, PRC.
The agenda includes four ordinary resolutions: approving the Purchase Framework Agreement and the transactions under it; approving the Logistic Support Services Framework Agreement and the transactions under it; reappointing Mr. Li Qiang as an independent non-executive director; and approving the change of company type. The proxy form must be completed and submitted according to the instructions specified in the announcement, and attendance at the meeting remains possible for shareholders who submit proxies by the required deadline.
Comments